Fig. 1From: Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trialsFlow-chart patient inclusion. DCIS, Ductal Carcinoma in Situ. Included patients were those diagnosed with DCIS between 2000 and 2014 whose initial biopsy was performed at the Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital or who were referred to the Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital for a second opinionBack to article page